Brief: Singular Genomics Systems Posts Q4 Loss Per Share Of $0.27
02/03/2022 21:39
March 2 (Reuters) - Singular Genomics Systems Inc OMIC.O :
* SINGULAR GENOMICS SYSTEMS, INC. REPORTS RECENT HIGHLIGHTS,
FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS
* Q4 LOSS PER SHARE $0.27
* SINGULAR GENOMICS - CASH, CASH EQUIVALENTS AND SHORT-TERM
INVESTMENTS, EXCLUDING RESTRICTED CASH, AS OF DEC 31, 2021
TOTALED ABOUT $339.2 MILLION
Source text for Eikon: ID:nGNX54nk1h
Further company coverage: OMIC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Singular Genomics Systems
See all newsBrief: Singular Genomics Systems Inc Deerfield Increases Purchase Price To $24.00 Per Share
Brief: Singular Genomics Receives Non-Binding Acquisition Proposal From Concentra Biosciences And Tang Capital
Singular Genomics up after Tang Capital offers to buy it
Brief: Tang Capital Management, Llc Reports 14.9% Stake In Singular Genomics Systems Inc As Of Sept 16 - SEC Filing
Brief: Singular Genomics Receives Non-Binding Acquisition Proposal From Deerfield